OMNI® purification system sanguine
- Risk class
- III
- Product type
- Active
- Brand name
- OMNI®
- Commercial name
- Hemodialysis Units
- Analysis ID
- a5cfc1cfe70e60c3f1bd17fb7ae67985
- Registration date
- December 29, 2022
- Expiration date
- December 29, 2027
- Country
- GERMANY
- Address
- AM BUSCHEBERG 1 34212 MELSUNGEN ALEMANIA
- Name
- B. BRAUN AVITUM AG
- Country
- GERMANY
- Address
- MANUEL AMBROSI E4-120 AND THE CYPRESSES
- Phone
- 22611312
OMNI IS USED TO PERFORM TREATMENTS CONTINUOUS BLOOD PURIFICATION, HEMODIALYSIS THERAPIES, THERAPEUTIC PLASMA EXCHANGE WITH EXTRACTION OF PLASMA COMPONENTS. OMNI IS USED IN PATIENTS WITH ACUTE RENAL FAILURE AND/OR FLUID OVERLOAD, AND/OR POISONING, WHO REQUIRE CONTINUOUS BLOOD PURIFICATION TREATMENTS. FOR THERAPEUTIC PLASMA EXCHANGE (TPE) TREATMENTS IN PATIENTS WITH VARIOUS DISEASES WHERE EPT HAS BEEN PRESCRIBED.
Access comprehensive regulatory information for OMNI® purification system sanguine in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID a5cfc1cfe70e60c3f1bd17fb7ae67985 and manufactured by B. BRAUN AVITUM AG. The device was registered on December 29, 2022.
This page provides complete registration details including product type (Active), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.